Skip to main content
Journal cover image

Serum proteomic biomarkers diagnostic of knee osteoarthritis.

Publication ,  Journal Article
Kraus, VB; Reed, A; Soderblom, EJ; Golightly, YM; Nelson, AE; Li, Y-J
Published in: Osteoarthritis and cartilage
March 2024

To better understand the pathogenesis of knee osteoarthritis (OA) through identification of serum diagnostics.We conducted multiple reaction monitoring mass spectrometry analysis of 107 peptides in baseline sera of two cohorts: the Foundation for National Institutes of Health (NIH) (n = 596 Kellgren-Lawrence (KL) grade 1-3 knee OA participants); and the Johnston County Osteoarthritis Project (n = 127 multi-joint controls free of radiographic OA of the hands, hips, knees (bilateral KL=0), and spine). Data were split into (70%) training and (30%) testing sets. Diagnostic peptide and clinical data predictors were selected by random forest (RF); selection was based on association (p < 0.05) with OA status in multivariable logistic regression models. Model performance was based on area under the curve (AUC) of receiver operating characteristic (ROC) and precision-recall (PR) curves.RF selected 23 peptides (19 proteins) and body mass index (BMI) as diagnostic of OA. BMI weakly diagnosed OA (ROC-AUC 0.57, PR-AUC 0.812) and only symptomatic OA cases. ACTG was the strongest univariable predictor (ROC-AUC 0.705, PR-AUC 0.897). The final model (8 serum peptides) was highly diagnostic (ROC-AUC 0.833, 95% confidence interval [CI] 0.751, 0.905; PR-AUC 0.929, 95% CI 0.876, 0.973) in the testing set and equally diagnostic of non-symptomatic and symptomatic cases (AUCs 0.830-0.835), and not significantly improved with addition of BMI. The STRING database predicted multiple high confidence interactions of the 19 diagnostic OA proteins.No more than 8 serum protein biomarkers were required to discriminate knee OA from non-OA. These biomarkers lend strong support to the involvement and cross-talk of complement and coagulation pathways in the development of OA.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Osteoarthritis and cartilage

DOI

EISSN

1522-9653

ISSN

1063-4584

Publication Date

March 2024

Volume

32

Issue

3

Start / End Page

329 / 337

Related Subject Headings

  • Proteomics
  • Peptides
  • Osteoarthritis, Knee
  • Knee Joint
  • Humans
  • Biomarkers
  • Arthritis & Rheumatology
  • 4207 Sports science and exercise
  • 3202 Clinical sciences
  • 1106 Human Movement and Sports Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Kraus, V. B., Reed, A., Soderblom, E. J., Golightly, Y. M., Nelson, A. E., & Li, Y.-J. (2024). Serum proteomic biomarkers diagnostic of knee osteoarthritis. Osteoarthritis and Cartilage, 32(3), 329–337. https://doi.org/10.1016/j.joca.2023.09.007
Kraus, Virginia Byers, Alexander Reed, Erik J. Soderblom, Yvonne M. Golightly, Amanda E. Nelson, and Yi-Ju Li. “Serum proteomic biomarkers diagnostic of knee osteoarthritis.Osteoarthritis and Cartilage 32, no. 3 (March 2024): 329–37. https://doi.org/10.1016/j.joca.2023.09.007.
Kraus VB, Reed A, Soderblom EJ, Golightly YM, Nelson AE, Li Y-J. Serum proteomic biomarkers diagnostic of knee osteoarthritis. Osteoarthritis and cartilage. 2024 Mar;32(3):329–37.
Kraus, Virginia Byers, et al. “Serum proteomic biomarkers diagnostic of knee osteoarthritis.Osteoarthritis and Cartilage, vol. 32, no. 3, Mar. 2024, pp. 329–37. Epmc, doi:10.1016/j.joca.2023.09.007.
Kraus VB, Reed A, Soderblom EJ, Golightly YM, Nelson AE, Li Y-J. Serum proteomic biomarkers diagnostic of knee osteoarthritis. Osteoarthritis and cartilage. 2024 Mar;32(3):329–337.
Journal cover image

Published In

Osteoarthritis and cartilage

DOI

EISSN

1522-9653

ISSN

1063-4584

Publication Date

March 2024

Volume

32

Issue

3

Start / End Page

329 / 337

Related Subject Headings

  • Proteomics
  • Peptides
  • Osteoarthritis, Knee
  • Knee Joint
  • Humans
  • Biomarkers
  • Arthritis & Rheumatology
  • 4207 Sports science and exercise
  • 3202 Clinical sciences
  • 1106 Human Movement and Sports Sciences